Junshi Biosciences Announces NMPA Accepted supplemental New Drug Application for Toripalimab in Combination with Chemotherapy as First-Line Treatment of Advanced NSCLC

6th indication for toripalimab submitted in China SHANGHAI, China, Dec. 10, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the National Medical Products Administration (the “NMPA”) has accepted the company’s supplemental New Drug Application (“sNDA”) […]

Spend Matters Secures Investment From Copley Equity Partners

Proceeds to Fund Continued Growth in Procurement While Expanding into Adjacent Markets BOSTON, Dec. 09, 2021 (GLOBE NEWSWIRE) — Copley Equity Partners, LLC (“Copley”), a private investment firm focused on lower middle-market companies with strong growth opportunities, today announced that it has made an investment in Spend Matters, a proprietary tech-enabled data platform that drives […]

Imperial Capital Opens Authorized European Company in Milan, Italy to Conduct European Business and Names Julien Sida as its CEO

LOS ANGELES, Dec. 09, 2021 (GLOBE NEWSWIRE) — Imperial Capital Group, LLC (“Imperial Capital”) announced that its affiliate, Imperial Capital (International) LLP (“Imperial Capital International”), has completed the process of transitioning its Milan Branch into an authorized subsidiary amidst the end of the Brexit transition period whereby passporting between the UK and EEA states ceased. […]

Unifty: Marrying DeFi and NFTs Through the Gallery

Unifty LONDON, Dec. 09, 2021 (GLOBE NEWSWIRE) — Unifty is marrying DeFi and NFTs with the launch of The Gallery, an innovative exhibition space inspired by the platform’s desire to improve upon the traditional gallery-creator relationship. The Gallery’s unique approach to the NFT marketplace means that all participants, including creators, collectors, curators, and fans, are […]